KDX-0811

Dexrazoxane · Kissei Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KDX-0811, covering 2015-03-13 to 2015-03-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents [Phase 1, Phase 2]

See pricing